CN Stock MarketDetailed Quotes

Hebei Changshan Biochemical Pharmaceutical (300255)

Watchlist
  • 41.81
  • -0.71-1.67%
Market Closed Mar 13 15:00 CST
38.43BMarket Cap-127.47P/E (TTM)

Hebei Changshan Biochemical Pharmaceutical (300255) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Low molecular weight heparin preparation204.49M41.60%
Total special adjustments181.28M36.87%
Common heparin drug94.01M19.12%
Other business11.83M2.41%

By Industry

Currency:CNY
2025/H1
Stock NameRevenueRatio
Water needle preparation233.38M47.47%
肝素原料药192.92M39.24%
Other65.31M13.29%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Domestic387.37M78.80%
Abroad104.24M21.20%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More